NEW YORK, Feb. 25, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”) of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, both dates inclusive (the “Class Period”), of the…

Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reaction The US FDA recently approved Xolair as the first and only…

NEW YORK, Feb. 25, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, both dates inclusive (the “Class Period”), of the important March 19, 2024 lead…

NEW YORK, Feb. 25, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Archer-Daniels-Midland Company (NYSE: ADM) between April 30, 2020 and January 22, 2024, both dates inclusive (the “Class Period”), of the important March…